Avigra FC tablets
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of erectile dysfunction in adult men.
Dosage (summary)
Initial dose of 50 mg taken approximately 1 hour before sexual activity; may be adjusted to 25 mg or 100 mg based on efficacy and tolerability.
Onset of Action / Duration
Effects typically begin within 30 to 60 minutes and can last for up to 4 hours.
Special Populations
- Elderly patients may require dose adjustment.
- Patients with hepatic impairment should start with a lower dose.
- Patients with renal impairment may require dose adjustment.
Pregnancy & Breastfeeding
Not indicated for use in women; safety during pregnancy and lactation has not been established.
Key Drug Interactions
- Nitrates (e.g., nitroglycerin) can cause severe hypotension when used with sildenafil.
- Alpha-blockers may enhance the hypotensive effects of sildenafil.
- CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) may increase sildenafil levels.
Contraindications
- Hypersensitivity to sildenafil or any component of the formulation.
- Concurrent use of nitrates in any form.
- Severe cardiovascular disorders where sexual activity is inadvisable.
Common side effects
- Headache
- Flushing
- Dyspepsia
- Nasal congestion
- Visual disturbances
- Priapism (prolonged erection)
Counselling Points
- Take sildenafil as needed, not more than once daily.
- Avoid high-fat meals before taking sildenafil as it may delay onset.
- Inform healthcare provider of any other medications being taken.
- Seek immediate medical attention for an erection lasting more than 4 hours.
Serious warnings
- Use with caution in patients with a history of cardiovascular disease.
- May cause dizziness; caution when driving or operating machinery.
- Not for use in women or children.
The Avigra FC tablets professional information leaflet below is the property of Upjohn South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.